Dermata Therapeutics(DRMA)
$0.62-0.04 (-5.91%)
DRMA
Dermata Therapeutics earnings date
$0.62
At close:-0.04 (-5.91%)
Want to see DRMA full AI Analyst Report?
Dermata Therapeutics (DRMA) Q2 2021 Earnings Report
160 Followers
DRMA Q2 2021 EPS Results
- Actual EPS
- -$1,680.00
- Consensus EPS
- -$168.00
- Beat/Miss
- Missed by -$1,512.00
- One Year Ago EPS
- -$236.76
DRMA Q2 2021 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 09/27/2021
- Time
- After Close
- Conference Call
- Monday, September 27, 2021
DRMA Upcoming Earnings
Dermata Therapeutics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DRMA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | -0.46- | -0.35 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.55-0.55 | -1.65 | 66.67% (+1.10) | |
| Aug 11, 2026 | 2026 (Q2) | -0.55-0.74 | -1.66 | 55.42% (+0.92) | |
| May 13, 2026 | 2026 (Q1) | -0.53-0.48 | -4.5 | 89.33% (+4.02) | |
| Mar 26, 2026 | 2025 (Q4) | -1.54-0.35 | -13.4 | 97.39% (+13.05) | |
| Nov 14, 2025 | 2025 (Q3) | -1.59-1.65 | -20.4 | 91.91% (+18.75) | |
| Aug 13, 2025 | 2025 (Q2) | -2.90-1.66 | -41.8 | 96.03% (+40.14) | |
| May 14, 2025 | 2025 (Q1) | -4.50-4.50 | -4.7 | 4.26% (+0.20) | |
| Mar 17, 2025 | 2024 (Q4) | -15.00-13.40 | -67.5 | 80.15% (+54.10) | |
| Nov 13, 2024 | 2024 (Q3) | -26.40-20.40 | -81 | 74.81% (+60.60) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
